For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities under the companies act for:

(a) ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the

Companies Act 2006 or the Act and

(b) preparing financial statements which give a true and fair view of the state of affairs of the company as at

the end of each financial year and of its profit or loss for each financial year in accordance with the

requirements of Sections 394 and 395 and which otherwise comply with the requirements of the

Companies Act 2006 relating to financial statements, so far as applicable to the company.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

Batri Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 6 Bridgend Business Centre, Bennett Street, Bridgend, Mid Glamorgan, UK, CF31 3SH.

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company has net current liabilities of £646,747 and total liabilities of £565,424 (2024: £363,787 and £314,507 respectively). The directors have confirmed their continued support for the business, so the accounts have been produced on the going concern basis.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated

useful life.

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at

the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods

different from those in which they are recognised in financial statements. Deferred tax is measured

using tax rates and laws that have been enacted or substantively enacted by the year end and that are

expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable

that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the

company's pension scheme are charged to profit or loss in the period to which they relate.

Share-based payments

Equity-settled transactions

The cost of equity-settled transactions with employees is measured by reference to the fair value of the

equity instruments granted at the date at which they are granted and is recognised as an expense over

the vesting period, which ends on the date on which the relevant employees become fully entitled to

the award. Fair value is determined by an external valuer using an appropriate pricing model. In valuing

equity-settled transactions, no account is taken of any vesting conditions, other than conditions linked

to the price of the shares of the company (market conditions) and non vesting conditions. No expense

is recognised for awards that do not ultimately vest, except for awards where vesting is conditional

upon a market or non vesting condition, which are treated as vesting irrespective of whether or not the

market or non vesting condition is satisfied, provided that all other performance conditions are

satisfied.

At each balance sheet date before vesting, the cumulative expense is calculated, representing the

extent to which the vesting period has expired and management's best estimate of the achievement or

otherwise of non-market conditions and of the number of equity instruments that will ultimately vest or

in the case of an instrument subject to a market condition, be treated as vesting as described above.

The movement in cumulative expense since the previous balance sheet date is recognised in the

income statement, with a corresponding entry in equity.

Where the terms of an equity-settled award are modified or a new award is designated as replacing a

cancelled or settled award, the cost based on the original award terms continues to be recognised over

the original vesting period. In addition, an expense is recognised over the remainder of the new vesting

period for the incremental fair value of any modification, based on the difference between the fair value

of the original award and the fair value of the modified award, both as measured on the date of the

modification. No reduction is recognised if this difference is negative.

Where an equity-settled award is cancelled, it is treated as if it had vested on the date of cancellation,

and any cost not yet recognised in the profit and loss account for the award is expensed immediately.

Any compensation paid up to the fair value of the award at the cancellation or settlement date is

deducted from equity, with any excess over fair value expensed in the profit and loss account.

The average monthly number of persons (including directors) employed by the company during the year was:

Subsidiary name: Batri US Inc

Registered Office: 8 The Green, STE B, Dover, Kent County, DE 19901, United States

Class of shares: Common

Shares Held: 85.25%

Included in creditors is an amount of £140,854 (2024: £55,526) due to one of the directors. This amount

is repayable on demand.

Included in creditors are loan amounts totalling £358,416 (2024: £311,570) due to companies in

which a director is also a director.

An Enterprise Management Incentive share option scheme was approved in 2024. Under this scheme

the options will vest if the employees who have been granted the options satisfy the working time

requirements for the period up to and including the date of sale of the company. The options will lapse

should the employee either leave employment or not meet the defined working time requirements. The

contractual life of the options is ten years from the date of approval. During the year there were

no share options granted (2024: 56,000) and none were forfeited (2024: none). As at 31 December

2025 the total number of options granted which have not lapsed is 56,000 (2024: 56,000).

The exercise price for options outstanding at the end of the year was £0.10. There are no cash

settlement alternatives. The fair value of these equity settled options was estimated as at the date of

grant based on a third party investment undertaken on an arms length basis and taking into account

performance of the business since that date and the terms and conditions upon which the options are

granted.

A second non - EMI share option scheme was approved in 2024. Under this scheme the options will

vest if the individuals who have been granted the options satisfy conditions up to and including the date

of sale of the company. The options will lapse should the individual either leave employment or not

meet the defined leaver requirements. The contractual life of the options is ten years. During the year

there were no share options granted (2024: 76,000) and none were forefeited (2024: none). As at

the 31 December 2025 the total number of options granted which have not lapsed is 76,000 (2024:

76,000).

The exercise price for options outstanding at the end of the year was £0.10. There are no cash

settlement alternatives. The fair value of equity settled options granted is estimated as at the date of

grant based on a third party investment undertaken on an arms length basis and taking into account

performance of the business since that date and the terms and conditions upon which the options are

granted.

A third non - EMI share option scheme was approved during the year, in 2024. Under this scheme the

options will vest if the individuals who have been granted the options satisfy conditions up to and

including the date of sale of the company. The options will lapse should the individual either leave

employment or not meet the defined leaver requirements. The contractual life of the options is ten

years. During the year there were no share options granted (2024: 9,000) and 6,000 forefeited (2024: none).

As at the 31 December 2025 the total number of options granted which have not lapsed is 3,000 (2024: 9,000).

The exercise price the for options outstanding at the end of the year was £0.10. There are no cash

settlement alternatives. The fair value of equity settled options granted is estimated as at the date of

grant based on a third party investment undertaken on an arms length basis and taking into account

performance of the business since that date and the terms and conditions upon which the options are

granted.

The expense recognised for these equity settled share-based payments during the year to 31

December 2025 is £nil (2024: £nil).